Clinical Trial Update: Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing adding venetoclax to FLAMSA/treosulfan conditioning for allogeneic stem cell transplantation in patients with myelodysplast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Amsacrine (amsacrine)
• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• Treosulfan (treosulfan)
• Venetoclax (venetoclax)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING